dFDA LogoFDA.gov v2

Clinical Trials for Type 2 Diabetes

Focusing on: DPP-4 Inhibitors

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 861 results.

Page 1 of 87

Use of Incretins in Diabetic Patients

Completed
Interventions:DPP-4 inhibitors
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 2234
Age: From 18 Years
Gender: ALL
Locations: IRCCS Policlinico San Matteo Foundation
Last Updated: N/A
View Study Details

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Completed
Conditions:Type 2 Diabetes
Study Type:
INTERVENTIONAL
Phase:
PHASE2
Enrollment: 64
Age: 18 Years - 75 Years
Gender: ALL
Locations: Chu Hsien-I Memorial Hospital, Tianjin Medical University
Last Updated: N/A
View Study Details

Study of Sulphonylurea Synergy With DPP4 Inhibitors

Completed
Conditions:Type 2 Diabetes
Study Type:
INTERVENTIONAL
Phase:
NA
Enrollment: 30
Age: 40 Years - 80 Years
Gender: ALL
Locations: Ninewells Hospital and Medical School
Last Updated: N/A
View Study Details

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Terminated
Study Type:
INTERVENTIONAL
Phase:
NA
Enrollment: 5
Age: 18 Years - 75 Years
Gender: ALL
Locations: Gastroenterology Department Erasme Hospital
Last Updated: N/A
View Study Details

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Completed
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 333580
Age: From 18 Years
Gender: ALL
Locations: RTI health solutions
Last Updated: N/A
Has Results
View Study Details

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Completed
Study Type:
INTERVENTIONAL
Phase:
PHASE3
Enrollment: 106
Age: From 20 Years
Gender: ALL
Locations: N/A
Last Updated: N/A
View Study Details

Empa PASS on Urinary Tract Malignancies

Completed
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 344995
Age: From 18 Years
Gender: ALL
Locations: The National Register Data; The Swedish prescribed drug register; +1 more
Last Updated: N/A
Has Results
View Study Details

The Effect of DPP4 Inhibitor on Vasclular Healing

Unknown Status
Last Known: RECRUITING
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 66
Age: From 20 Years
Gender: ALL
Locations: Keimyung University Hospital; Chonnam National University Hospital; +4 more
Last Updated: N/A
Join Study

Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

Recruiting
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 200
Age: From 18 Years
Gender: ALL
Locations: BSMMU
Last Updated: N/A
Join Study

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Unknown Status
Last Known: RECRUITING
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 550000
Age: From 30 Years
Gender: ALL
Locations: HealthCore, Inc.; Humana; +3 more
Last Updated: N/A
Join Study